mapap arthritis pain

Major Pharmaceuticals

Major Pharmaceuticals Mapap® Arthritis Pain Drug Facts

FULL PRESCRIBING INFORMATION: CONTENTS*

• Active ingredient (in each caplet)
• Purpose
• mapap arthritis pain Uses
• Warnings
  • Do not use
  • Ask a doctor before use if you have
  • Ask a doctor or pharmacist before use if you are
  • Stop use and ask a doctor if
  • If pregnant or breast-feeding,
  • Keep out of reach of children.
• Directions
• mapap arthritis pain Other information
• Inactive ingredients
• Questions or comments?
• Principal Display Panel

FULL PRESCRIBING INFORMATION

Active ingredient (in each caplet)

Acetaminophen 650 mg

Purpose

Pain reliever/fever reducer

mapap arthritis pain Uses

• •temporarily relieves minor aches and pains due to:
• •minor pain of arthritis
• •muscular aches
• •backache
• •premenstrual and menstrual cramps
• •the common cold
• •headache
• •toothache
• •temporarily reduces fever

Warnings

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take

• •more than 6 caplets in 24 hours, which is the maximum daily amount
• •with other drugs containing acetaminophen
• •3 or more alcoholic drinks every day while using this product

Do not use

• •with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
• •if you are allergic to acetaminophen or any of the inactive ingredients in this product

Ask a doctor before use if you have

liver disease

Ask a doctor or pharmacist before use if you are

taking the blood thinning drug warfarin

Stop use and ask a doctor if

• •pain gets worse or lasts more than 10 days
• •fever gets worse or lasts more than 3 days
• •new symptoms occur
• •redness or swelling is present

These could be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

• •do not take more than directed (see overdose warning)

take 2 caplets every 8 hours with water

swallow whole – do not crush, chew, split or dissolve

do not take more than 6 caplets in 24 hours

do not use for more than 10 days unless directed by a doctorask a doctor

•

•

•

•

•

adults
under 18 years of age

mapap arthritis pain Other information

• •store at 20°-25°C (68°-77°F). Avoid excessive heat 40°C (104°F).
• •see end panel for lot number and expiration date

Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, polysorbate 80, povidone, pregelatinized starch, stearic acid, titanium dioxide

Questions or comments?

1-800-719-9260

Principal Display Panel

TEMPORARY, MINOR

Mapap® ARTHRITIS PAIN

Acetaminophen Extended-Release Tablets, 650 mg

PAIN RELIEVER

FEVER REDUCER

COMPARE TO active ingredient of TYLENOL® ARTHRITIS PAIN

650 mg EACH

*Capsule-shaped tablets

mapap arthritis pain Acetaminophen TABLET, FILM COATED, EXTENDED RELEASE Product Information Product Type Human otc drug label Item Code (Source) NDC:0904-5769 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAMINOPHEN ACETAMINOPHEN 650 mg Inactive Ingredients Ingredient Name Strength carnauba wax SILICON DIOXIDE CROSCARMELLOSE SODIUM HYPROMELLOSES MAGNESIUM STEARATE maltodextrin cellulose, microcrystalline POLYETHYLENE GLYCOLS polysorbate 80 POVIDONES STEARIC ACID titanium dioxide Product Characteristics Color Size Imprint Code Shape WHITE 19 mm L544 CAPSULE Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 100 in 1 BOTTLE 2 NDC:0904-5769-60 1 in 1 CARTON Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA075077 2006-02-16